{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T12:09:06Z","timestamp":1778933346539,"version":"3.51.4"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T00:00:00Z","timestamp":1762041600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017415","name":"Peking University First Hospital","doi-asserted-by":"publisher","award":["2024SF58"],"award-info":[{"award-number":["2024SF58"]}],"id":[{"id":"10.13039\/100017415","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Exploratory Research in Clinical and Social Pharmacy"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.rcsop.2025.100681","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T05:56:31Z","timestamp":1762322191000},"page":"100681","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The impact of comprehensive pharmaceutical care on medication safety in gynecologic oncology chemotherapy patients"],"prefix":"10.1016","volume":"20","author":[{"given":"Zhiqi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianxin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan","family":"Mi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Lian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaocong","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rcsop.2025.100681_bb0005","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.rcsop.2025.100681_bb0010","first-page":"24","article-title":"Expert consensus on the clinical application of pegylated liposomal doxorubicin in gynecologic malignancies","volume":"12","author":"Kong","year":"2020","journal-title":"Chin J Front Med (Electronic Edition)"},{"key":"10.1016\/j.rcsop.2025.100681_bb0015","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/1552-6909.12300","article-title":"Late and long-term effects of breast cancer treatment and surveillance management for the general practitioner","volume":"43","author":"Kenyon","year":"2014","journal-title":"J Obstet Gynecol Neonatal Nurs"},{"key":"10.1016\/j.rcsop.2025.100681_bb0020","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1016\/j.breast.2015.07.035","article-title":"Long term side effects of adjuvant chemotherapy in patients with early breast cancer","volume":"24","author":"Tao","year":"2015","journal-title":"Breast"},{"key":"10.1016\/j.rcsop.2025.100681_bb0025","first-page":"897","article-title":"Expert consensus on the hierarchical management of antitumor drugs","volume":"43","author":"Dai","year":"2021","journal-title":"Chin J Oncol"},{"key":"10.1016\/j.rcsop.2025.100681_bb0030","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/annonc\/mdt433","article-title":"Factors influencing adherence to cancer treatment in older adults with cancer: a systematic review","volume":"25","author":"Puts","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.rcsop.2025.100681_bb0035","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000021695","article-title":"Relationship between chemotherapy-induced adverse reactions and health-related quality of life in patients with breast cancer","volume":"99","author":"Prieto-Callejero","year":"2020","journal-title":"Medicine"},{"key":"10.1016\/j.rcsop.2025.100681_bb0040","doi-asserted-by":"crossref","first-page":"E310","DOI":"10.1188\/15.ONF.E310-E318","article-title":"Effect of a nurse-led psychoeducational intervention on healthcare service utilization among adults with advanced cancer","volume":"42","author":"Martinez","year":"2015","journal-title":"Oncol Nurs Forum"},{"key":"10.1016\/j.rcsop.2025.100681_bb0045","series-title":"The role of hematology\/oncology pharmacists [internet]","year":"2014"},{"key":"10.1016\/j.rcsop.2025.100681_bb0050","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1177\/1078155218782372","article-title":"Clinical pharmacists\u2019 contributions to hematopoietic stem cell transplantation: a systematic review","volume":"25","author":"Barboza-Zanetti","year":"2019","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.rcsop.2025.100681_bb0055","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.2146\/ajhp160475","article-title":"Impact of clinical pharmacists in outpatient oncology practices: a review","volume":"74","author":"Gatwood","year":"2017","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.rcsop.2025.100681_bb0060","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1177\/1078155220976801","article-title":"Impact of clinical pharmacy in oncology and hematology centers: a systematic review","volume":"27","author":"Oliveira","year":"2021","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.rcsop.2025.100681_bb0065","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.japh.2020.12.005","article-title":"Pharmacist-led collaborative medication management programs for oral antineoplastic therapies: a systematic literature review","volume":"61","author":"Passey","year":"2021","journal-title":"J Am Pharm Assoc"},{"key":"10.1016\/j.rcsop.2025.100681_bb0070","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1177\/1078155219859424","article-title":"Demonstrating the value of the oncology pharmacist within the healthcare team","volume":"25","author":"Segal","year":"2019","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.rcsop.2025.100681_bb0075","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40780-014-0007-y","article-title":"Pharmacoeconomic effect of compliance with pharmacist\u2019s intervention based on cancer chemotherapy regimens: a cohort study","volume":"1","author":"Hayashi","year":"2015","journal-title":"J Pharm Health Care Sci"},{"key":"10.1016\/j.rcsop.2025.100681_bb0080","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/ajhp\/56.13.1330","article-title":"Economic and clinical impact of a pharmacy-based filgrastim protocol in oncology patients","volume":"56","author":"Bernstein","year":"1999","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.rcsop.2025.100681_bb0085","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1248\/bpb.b17-00501","article-title":"A retrospective study of the effects of oncology pharmacist participation in treatment on therapeutic outcomes and medical costs","volume":"40","author":"Imamura","year":"2017","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.rcsop.2025.100681_bb0090","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/ejhpharm-2016-000937","article-title":"Pharmacist-led interdisciplinary medication reconciliation using comprehensive medication review in gynaecological oncology patients: a prospective study","volume":"25","author":"Son","year":"2018","journal-title":"Eur J Hosp Pharm"},{"key":"10.1016\/j.rcsop.2025.100681_bb0095","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2021.32.e53","article-title":"Major clinical research advances in gynecologic cancer in 2020","volume":"32","author":"Lee","year":"2021","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.rcsop.2025.100681_bb0100","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s13178-024-00974-9","article-title":"Factors influencing the provision of healthcare professional-led sexual support to patients with cancer and their partners: an integrative review of studies from 2017 to 2022","volume":"22","author":"Bingham","year":"2025","journal-title":"Sex Res Soc Policy"},{"key":"10.1016\/j.rcsop.2025.100681_bb0105","first-page":"638","article-title":"Guidelines for the standardized management of chemotherapy-induced neutropenia in oncology radiotherapy and chemotherapy, Chinese Society of Clinical Oncology (CSCO) (2021)","volume":"26","author":"Qin","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.rcsop.2025.100681_bb0110","series-title":"Hematopoietic growth factors [internet]","year":"2025"},{"key":"10.1016\/j.rcsop.2025.100681_bb0115","first-page":"86","article-title":"Expert consensus on the diagnosis and treatment of chemotherapy-induced neutropenia (2019 edition)","volume":"11","author":"Shi","year":"2019","journal-title":"Chin J Front Med (Electr Ed)"},{"issue":"95","key":"10.1016\/j.rcsop.2025.100681_bb0120","first-page":"3001","article-title":"Expert consensus on the clinical application of recombinant human granulocyte colony-stimulating factor in cancer chemotherapy (2015 edition)","author":"Oncology Physicians Branch of the Chinese Medical Association","year":"2015","journal-title":"Chin Med J"},{"key":"10.1016\/j.rcsop.2025.100681_bb0125","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/cad.20309","article-title":"Propensity score analysis in non-randomized experimental designs: an overview and a tutorial using R software","volume":"2019","author":"Kim","year":"2019","journal-title":"New Dir Child Adolesc Dev"},{"key":"10.1016\/j.rcsop.2025.100681_bb0130","first-page":"221","article-title":"Analysis of the epidemiology of malignant tumors in China in 2022","volume":"46","author":"Zheng","year":"2024","journal-title":"Chin J Oncol"},{"key":"10.1016\/j.rcsop.2025.100681_bb0135","doi-asserted-by":"crossref","first-page":"6645","DOI":"10.1039\/C8DT00838H","article-title":"The side effects of platinum-based chemotherapy drugs: a review for chemists","volume":"47","author":"Oun","year":"2018","journal-title":"Dalton Trans"},{"key":"10.1016\/j.rcsop.2025.100681_bb0140","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1177\/1078155218807748","article-title":"Clinical oncology pharmacist: effective contribution to patient safety","volume":"25","author":"Duarte","year":"2019","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.rcsop.2025.100681_bb0145","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/1078155206070412","article-title":"An evaluation of pharmacist contribution to an oncology ward in a Swedish hospital","volume":"12","author":"Bremberg","year":"2006","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.rcsop.2025.100681_bb0150","first-page":"457","article-title":"Impact of clinical pharmacy services in a hematology\/oncology inpatient setting","volume":"35","author":"Delpeuch","year":"2015","journal-title":"Anticancer Res"},{"key":"10.1016\/j.rcsop.2025.100681_bb0155","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1365-2753.2011.01665.x","article-title":"Pharmacists contribute to the improved efficiency of medical practices in the outpatient cancer chemotherapy clinic","volume":"18","author":"Iihara","year":"2012","journal-title":"J Eval Clin Pract"},{"key":"10.1016\/j.rcsop.2025.100681_bb0160","first-page":"183","article-title":"A randomized trial of the effects of pharmacist intervention on the cost of antiemetic therapy with ondansetron","volume":"3","author":"Dranitsaris","year":"1995","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.rcsop.2025.100681_bb0165","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0009-9236(96)90060-0","article-title":"Cost-effectiveness analysis of serum vancomycin concentration monitoring in patients with hematologic malignancies","volume":"60","author":"del Mar Fern\u00e1ndez de Gatta","year":"1996","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.rcsop.2025.100681_bb0170","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1007\/s12185-010-0583-z","article-title":"A prospective study to evaluate the feasibility and economic benefits of rapid infusion rituximab at an Asian cancer center","volume":"91","author":"Chiang","year":"2010","journal-title":"Int J Hematol"},{"key":"10.1016\/j.rcsop.2025.100681_bb0175","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1093\/ajhp\/52.17.1879","article-title":"Cost-reducing treatment algorithms for antineoplastic drug-induced nausea and vomiting","volume":"52","author":"Berard","year":"1995","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.rcsop.2025.100681_bb0180","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/1078155213476723","article-title":"Dose rounding of ipilimumab in adult metastatic melanoma patients results in significant cost savings","volume":"20","author":"Jarkowski","year":"2014","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.rcsop.2025.100681_bb0185","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1177\/1078155218760704","article-title":"ClotAssist: A program to treat cancer-associated thrombosis in an outpatient pharmacy setting","volume":"25","author":"Easaw","year":"2019","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.rcsop.2025.100681_bb0190","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1191\/1078155205jp149oa","article-title":"Study of the effect of standardized chemotherapy order forms on prescribing errors and anti-emetic cost","volume":"11","author":"Sano","year":"2005","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.rcsop.2025.100681_bb0195","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/1078155212447974","article-title":"Economic impact of prescribing error prevention with computerized physician order entry of injectable antineoplastic drugs","volume":"19","author":"Nerich","year":"2013","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.rcsop.2025.100681_bb0200","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1177\/1078155219846958","article-title":"Automated parenteral chemotherapy dose-banding to improve patient safety and decrease drug costs","volume":"26","author":"Fahey","year":"2020","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.rcsop.2025.100681_bb0205","first-page":"8","article-title":"Pattern of adverse drug reactions due to cancer chemotherapy in tertiary care teaching hospital in Bangladesh","author":"Poddar","year":"2010","journal-title":"Dhaka Univ J Pharm Sci"},{"key":"10.1016\/j.rcsop.2025.100681_bb0210","doi-asserted-by":"crossref","first-page":"5305","DOI":"10.7314\/APJCP.2014.15.13.5305","article-title":"Side effects of chemotherapy among cancer patients in a Malaysian General Hospital: experiences, perceptions and informational needs from clinical pharmacists","volume":"15","author":"Chan","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.rcsop.2025.100681_bb0215","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2147\/DHPS.S116924","article-title":"Pattern of chemotherapy-related adverse effects among adult cancer patients treated at Gondar University Referral Hospital, Ethiopia: a cross-sectional study","volume":"8","author":"Belachew","year":"2016","journal-title":"Drug Healthc Patient Saf"},{"key":"10.1016\/j.rcsop.2025.100681_bb0220","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1200\/JOP.2012.000816","article-title":"Antiemetic guideline consistency and incidence of chemotherapy-induced nausea and vomiting in US community oncology practice: INSPIRE study","volume":"10","author":"Gilmore","year":"2014","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.rcsop.2025.100681_bb0225","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1093\/annonc\/mds021","article-title":"The effect of guideline-consistent antiemetic therapy on chemotherapy-induced nausea and vomiting (CINV): the Pan European Emesis registry (PEER)","volume":"23","author":"Aapro","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.rcsop.2025.100681_bb0230","first-page":"661","article-title":"The assessment of anorexia in patients with cancer: cut-off values for the FAACT\u2013A\/CS and the VAS for appetite","volume":"24","author":"Blauwhoff-Buskermolen","year":"2016","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.rcsop.2025.100681_bb0235","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.oraloncology.2014.06.009","article-title":"Nutrition impact symptoms in a population cohort of head and neck cancer patients: multivariate regression analysis of symptoms on oral intake, weight loss and survival","volume":"50","author":"Farhangfar","year":"2014","journal-title":"Oral Oncol"},{"key":"10.1016\/j.rcsop.2025.100681_bb0240","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1089\/jpm.2011.0098","article-title":"Clinical outcomes and contributors to weight loss in a cancer cachexia clinic","volume":"14","author":"Del Fabbro","year":"2011","journal-title":"J Palliat Med"},{"key":"10.1016\/j.rcsop.2025.100681_bb0245","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1200\/JCO.20.01399","article-title":"Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update","volume":"38","author":"Loprinzi","year":"2020","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.rcsop.2025.100681_bb0250","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1007\/s12325-020-01419-6","article-title":"Patient burden and real-world management of chemotherapy-induced myelosuppression: results from an online survey of patients with solid tumors","volume":"37","author":"Epstein","year":"2020","journal-title":"Adv Ther"},{"key":"10.1016\/j.rcsop.2025.100681_bb0255","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/cncr.11882","article-title":"Chemotherapy-induced neutropenia","volume":"100","author":"Crawford","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.rcsop.2025.100681_bb0260","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10549-017-4609-6","article-title":"Advantages with prophylactic PEG-rhG-CSF versus rhG-CSF in breast cancer patients receiving multiple cycles of myelosuppressive chemotherapy: an open-label, randomized, multicenter phase III study","volume":"168","author":"Xie","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.rcsop.2025.100681_bb0265","first-page":"667","article-title":"Neutropenia management and granulocyte colony-stimulating factor use in patients with solid tumours receiving myelotoxic chemotherapy\u2014findings from clinical practice","volume":"22","author":"Krzemieniecki","year":"2014","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.rcsop.2025.100681_bb0270","first-page":"367","article-title":"Adherence to granulocyte-colony stimulating factor (G-CSF) guidelines to reduce the incidence of febrile neutropenia after chemotherapy\u2014a representative sample survey in Germany","volume":"24","author":"Link","year":"2016","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.rcsop.2025.100681_bb0275","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1093\/jnci\/djr195","article-title":"Personalized medicine and cancer supportive care: appropriate use of colony-stimulating factor support of chemotherapy","volume":"103","author":"Kuderer","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.rcsop.2025.100681_bb0280","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1200\/JCO.2011.39.9980","article-title":"A way forward on the medically appropriate use of white cell growth factors","volume":"30","author":"Smith","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.rcsop.2025.100681_bb0285","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1200\/JOP.2012.000662","article-title":"Comparison of pegfilgrastim prescribing practice to national guidelines at a university hospital outpatient oncology clinic","volume":"9","author":"Waters","year":"2013","journal-title":"J Oncol Pract"}],"container-title":["Exploratory Research in Clinical and Social Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667276625001222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667276625001222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T11:26:28Z","timestamp":1778930788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667276625001222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":57,"alternative-id":["S2667276625001222"],"URL":"https:\/\/doi.org\/10.1016\/j.rcsop.2025.100681","relation":{},"ISSN":["2667-2766"],"issn-type":[{"value":"2667-2766","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of comprehensive pharmaceutical care on medication safety in gynecologic oncology chemotherapy patients","name":"articletitle","label":"Article Title"},{"value":"Exploratory Research in Clinical and Social Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rcsop.2025.100681","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100681"}}